Cyclosporine monitoring in renal transplant recipients with induction therapy: C2 levels in patients monitored on C0

Fundamental and Clinical Pharmacology

Volumn 20, Issue 1, 2006, Pages 91-96

  Loichot, Cécile ^a   Bentue Ferrer, Danièle ^b   Bernard, Nicole ^c   Bonardet, Andrée ^d   Boulieu, Roselyne ^e   Kergueris, Marie France ^f   Paintaud, Gilles ^g   Peytavin, Gilles ^h   Simon, Nicolas ⁱ   Marquet, Pierre ^j  

^a UNIVERSITY HOSPITAL OF STRASBOURG   (France)

^b Inst de Rech Contre le Cancer IRCC   (France)

^c FOCH HOSPITAL   (France)

^d LAPEYRONIE HOSPITAL   (France)

^e UNIVERSITÉ LYON 1   (France)

^f HÔTEL DIEU   (France)

^g UNIVERSITY HOSPITAL OF TOURS   (France)

^h BICHAT HOSPITAL   (France)

ⁱ AIX MARSEILLE UNIVERSITY   (France)

^j LIMOGES UNIVERSITY HOSPITAL   (France)

more..

Author keywords

C2 levels; Renal transplantation; Therapeutic drug monitoring of cyclosporine

Indexed keywords

CYCLOSPORIN;

ARTICLE; CLINICAL PRACTICE; DRUG BLOOD LEVEL; DRUG MONITORING; ENZYME IMMUNOASSAY; FLUORESCENCE POLARIZATION IMMUNOASSAY; FRANCE; GRAFT RECIPIENT; HUMAN; KIDNEY GRAFT; LONG TERM CARE; MAINTENANCE THERAPY; MAJOR CLINICAL STUDY; PATIENT MONITORING; POSTOPERATIVE PERIOD; PRIORITY JOURNAL; RETROSPECTIVE STUDY;

ANTIBODIES, MONOCLONAL; CYCLOSPORINE; DRUG MONITORING; DRUG THERAPY, COMBINATION; FRANCE; GRAFT REJECTION; HUMANS; IMMUNOSUPPRESSIVE AGENTS; INTERLEUKIN-12; KIDNEY TRANSPLANTATION; PRACTICE GUIDELINES; RETROSPECTIVE STUDIES;

EID: 33645028458     PISSN: 07673981     EISSN: 14728206     Source Type: Journal    
DOI: 10.1111/j.1472-8206.2005.00383.x     Document Type: Article

References (17)

1. Grevel J. Welsh M.S. Kahan B.D. Cyclosporine monitoring in renal transplantation: area under the curve monitoring is superior to trough-level monitoring Ther. Drug Monit. 1989 11 246 248
2. Mahalati K. Belitsky P. Sketris I. West K. Panek R. Neoral monitoring by simplified sparse sampling area under the concentration-time curve: its relationship to acute rejection and cyclosporine nephrotoxicity early after kidney transplantation Transplantation 1999 68 55 62
3. Canadian Neoral Renal Transplantation Study Group Absorption profiling of cyclosporine microemulsion (neoral) during the first 2 weeks after renal transplantation Transplantation 2001 72 1024 1032
4. Pescovitz M.D. Barbeito R. Two-hour post-dose cyclosporine level is a better predictor than trough level of acute rejection of renal allografts Clin. Transplant. 2002 16 378 382
5. Morris R.G. Russ G.R. Cervelli M.J. Juneja R. McDonald S.P. Mathew T.H. Comparison of trough, 2-hour, and limited AUC blood sampling for monitoring cyclosporin (Neoral) at day 7 post-renal transplantation and incidence of rejection in the first month Ther. Drug. Monit. 2002 24 479 486
6. Keown P. Landsberg D. Halloran P. et al. A randomized, prospective multicenter pharmacoepidemiologic study of cyclosporine microemulsion in stable renal graft recipients. Report of the Canadian Neoral Renal Transplantation Study Group Transplantation 1996 62 1744 1752
7. Halloran P.F. Helms L.M. Kung L. Noujaim J. The temporal profile of calcineurin inhibition by cyclosporine in vivo Transplantation 1999 68 1356 1361
8. Sindhi R. Lavia M.R. Pauling E. et al. Stimulated response of peripheral lymphocytes may distinguish cyclosporine effect in renal transplant recipients receiving a cyclosporine+rapamycin regimen Transplantation 2000 69 432 436
9. Thervet E. Pfeffer P. Scolari M.P. et al. Clinical outcomes during the first three months posttransplant in renal allograft recipients managed by C2 monitoring of cyclosporine microemulsion Transplantation 2003 76 903 908
10. Levy G. Thervet E. Lake J. Uchida K. Patient management by Neoral C(2) monitoring: an international consensus statement Transplantation 2002 73 S12 S18
11. Clase C.M. Mahalati K. Kiberd B.A. et al. Adequate early cyclosporin exposure is critical to prevent renal allograft rejection: patients monitored by absorption profiling Am. J. Transplant. 2002 2 789 795
12. Einecke G. Mai I. Fritsche L. et al. The value of C2 monitoring in stable renal allograft recipients on maintenance immunosuppression Nephrol. Dial. Transplant. 2004 19 215 222
13. Vathsala A. Lu Y.M. Abbreviated cyclosporine pharmacokinetic profiling in clinical renal transplantation: from principles to practice Transplant. Proc. 2001 33 3137 3139
14. Cole E. Maham N. Cardella C. et al. Clinical benefits of neoral C2 monitoring in the long-term management of renal transplant recipients Transplantation 2003 75 2086 2090
15. Singh D. Kiberd B. Belistsky P. Fraser A. Balbontin F. Lawen J. Therapeutic monitoring of cyclosporine in kidney transplantation: the Halifax experience Transplant. Proc. 2004 36 S414 S419
16. International Neoral renal transplantation study group Randomized, international study of cyclosporine microemulsion absorption profiling in renal transplantation with basiliximab immunoprophylaxis Am. J. Transplant. 2002 2 157 166
17. Birsan T. Loinig C. Bodingbauer M. et al. Comparison between C0 and C2 monitoring in de novo renal transplant recipients: retrospective analysis of a single-center experience Transplantation 2004 78 1787 1791